| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/16/2008 | US20080255170 Process for the Synthesis of Rosuvastatin Calcium |
| 10/16/2008 | US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread |
| 10/16/2008 | US20080255168 Methods for administering dpd inhibitors in combination with 5-fu and 5-fu prodrugs |
| 10/16/2008 | US20080255167 Novel 2-Aminopyrimidine or 2-Aminiopyridinone Derivatives and Their Use |
| 10/16/2008 | US20080255166 E.g., 5-dinitro-2-dimethyldithio-carbamoyl-pyridine; strong bacteriacidal activity, especially against mycobacteria; tuberculosis and leprosy caused by mycobacteria and infectious diseases caused by staphylococci; side effect reductions; effective against drug, multidrug-resistant infections |
| 10/16/2008 | US20080255165 Pharmaceutical Compositions of the Isolated D-Enantiomer of the Quinazolinone Derivative Halofuginone |
| 10/16/2008 | US20080255164 2-amino-6-(3-bromo-4-chlorophenyl)-5,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one trifluoroacetate; prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia |
| 10/16/2008 | US20080255163 Compounds such as 2-piperidino-6-methyl-5-oxo-5,6-dihydro-(7H) pyrrole-[3,4-d]pyrimidine maleate (MS-818); nervous system, brain, and neurodegenerative disorders; Parkinson's, Alzheimer's, and Huntington's disease |
| 10/16/2008 | US20080255162 Treating diseases mediated by phosphatidyl inositol 3-kinase; cardiovascular disorders; anticarcinogenic, antiarthritic, anticoagulant, antiinflammatory, antiischemic,and hypotensive agents; chronic obstructive pulmonary disease; autoimmune diseases; diabetes, atherosclerosis, bronchitis, strokes |
| 10/16/2008 | US20080255161 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| 10/16/2008 | US20080255160 Mapk/erk kinase inhibitors |
| 10/16/2008 | US20080255159 Arthritis, obesity, (non-insulin dependent) diabetes calcitonin-induced osteoporosis; administering allograft transplantation; dipeptidyl peptidase-IV (DPP-IV) inhibitors |
| 10/16/2008 | US20080255157 Promoting microtube polymerization; drug resistant cancer; 5-Azepan-1-yl-7-chloro-6-(2,4,6-trifluorophenyl)imidazo[1,2-a]pyrimidine |
| 10/16/2008 | US20080255156 2-Phenyl-s-triazolo[4,3-c]quinazolin-3-one derivatives; neurodegenerative and central nervous system disorders; Parkinson's and Alzheimer's disease; restless leg syndrome; sleep, attention deficit, and psychological disorders; antidepressants; strokes, psychosis |
| 10/16/2008 | US20080255155 Inhibit protein tyrosine kinase; treating cell proliferative diseases and conditions; N-(6-(2-Fluoro-4-(4,4,4-trifluoro-3-(4-fluorophenylamino)butanamido)phenoxy)pyrimidin-4-yl)pyrrolidine-1-carboxamide |
| 10/16/2008 | US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes |
| 10/16/2008 | US20080255153 New compounds |
| 10/16/2008 | US20080255152 Diaryl ethers as opioid receptor antagonists |
| 10/16/2008 | US20080255151 N-deacetylthiocolchicine deriatives, their use and pharmaceutical formulations containing them |
| 10/16/2008 | US20080255150 2-[(1-Piperazinyl)methyl]phenylacetic acid derivatives such as 3-(4-chloro-2-{[(3S)-3-methyl-4-(phenylacetyl)piperazin-1-yl]methyl}phenyl)propanoic acid; antihistamines, bronchodilator agents; asthma, rhinitis; treating prostaglandin D2 mediated disease |
| 10/16/2008 | US20080255149 1-Oxopiperidine derivatives; amides derived from fused and/or spiro polyheterocycles such as decahydro-(iso)quinoline, tetrahydro(iso)quinoline, piperazine, piperidine, indole, or (iso)indole; histone deacetylase inhibitors; antiproliferative, antitumor, and antitumor agents; hyperplasia; immune diseases |
| 10/16/2008 | US20080255148 Therapeutic agent for senile dementia |
| 10/16/2008 | US20080255147 Heterocycles useful as modulators of ion channels |
| 10/16/2008 | US20080255146 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy |
| 10/16/2008 | US20080255145 Thiadiazole compounds and methods of use |
| 10/16/2008 | US20080255144 (3'-Chloro-4-methanesulfonyl-biphenyl-2-yl)-[4-(3,4-dichloro-phenyl)-piperazin-1-yl]-methanone; neurological and neuropsychiatric disorders including schizophrenia |
| 10/16/2008 | US20080255143 Inhibitors of Akt Activity |
| 10/16/2008 | US20080255142 Substituted Piperidine Derivatives as Somatostatin Sst1 Receptor Antagonists |
| 10/16/2008 | US20080255141 Modulators of signal transduction mediated by certain native and/or mutant tyrosine kinases; antiproliferative, anticarcinogenic, antiallergen, and antiinflammatory agents; metabolic and neurodegenerative disorders |
| 10/16/2008 | US20080255140 2-(N'-2-amino-3,4-dioxocyclobutenyl)-N-piperazinyl)-pyrimidine-5-hydroxamic acid derivatives; antiproliferative, anticarcinogenic, and antitumor agents; psoriasis; skin, respiratory system, psychological, and genetic disorders; transplant rejection; Alzheimer's and Parkinson's disease; vision defects |
| 10/16/2008 | US20080255139 Use Of 4- (4-Methylpiperazin-1-Ylmethyl)-N-[4-Methyl-3-(4-(Pyridin-3-Yl)Pyrimidin-2-Ylamino)Phenyl]-Benzamide to Inhibit the Tyrosine Kinase Receptor C-Fms |
| 10/16/2008 | US20080255138 Novel Polymorphic Form Of Imatinib Mesylate And A Process For Its Preparation |
| 10/16/2008 | US20080255137 N-Biaryl and N-Arylheteroaryl 2-Substituted Piperazine Derivatives as Modulators of the 5ht2c Receptor Useful for the Treatment of Disorders Related Thereto |
| 10/16/2008 | US20080255136 Pyrrolidones with anti-hiv activity |
| 10/16/2008 | US20080255135 1-Aza-bicyclo[2.2.2]octane and 1-aza-bicyclo[2.2.1]heptane derivatives; psychotic, psychological, nervous system and neurodegenerative disorders; nicotinic receptor mediated diseases |
| 10/16/2008 | US20080255134 Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase |
| 10/16/2008 | US20080255133 N-(2-aylamino)aryl sulfonamides such as N-(7-(4-bromo-2-fluorophenylamino)imidazo[1,2-b]pyridazin-6-yl)-1-(2-hydroxyethyl)cyclopropane-1-sulfonamide; mitogen-activated ERK activating kinase (MEK) inhibitors; antiproliferative, anticarcinogenic, and antiinflammatory agents |
| 10/16/2008 | US20080255132 Combination Therapy Comprising the Use of Et-743 and Paclitaxel for Treating Cancer |
| 10/16/2008 | US20080255131 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands |
| 10/16/2008 | US20080255130 Bicyclic Nitrogen-containing Heterocyclic compounds for use as Stearoyl CoA Desaturase inhibitors |
| 10/16/2008 | US20080255129 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 10/16/2008 | US20080255128 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis |
| 10/16/2008 | US20080255126 Inhibitors of post-proline cleaving proteases |
| 10/16/2008 | US20080255125 Topically Applied Medicament for Animals |
| 10/16/2008 | US20080255124 4-[(Cyclopropylmethyl)(2-{[4-(1,1-dimethylethyl)phenyl]oxy}ethyl)amino]-2-(trifluoromethyl)benzonitrile; modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors; osteoporosis, muscle wasting,endometriosis, cardiovascular disease; breast, uterine cancer, prostatic hyperplasia |
| 10/16/2008 | US20080255123 (2Z)-2-(3-butyl-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene)-1-(5-chloro-2-methoxyphenyl)ethanone; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants |
| 10/16/2008 | US20080255122 Derivatives of Isothiazol-3(2H)-One 1,1-Dioxides as Liver X Receptor Modulators |
| 10/16/2008 | US20080255121 Combination Drug for Treating Autoimmune Disease |
| 10/16/2008 | US20080255120 Substituted 2,5-heterocyclic derivatives |
| 10/16/2008 | US20080255119 e.g. 5-[rac-cis-2,3-Bis-(4-chloro-phenyl)-5-oxo-2,3-dihydro-5H-imidazo[1,2-a]pyridine-1-sulfonyl]-2-fluoro-benzonitrile; inhibit the interaction of tumor suppressor MDM2 protein with a p53-like peptide; antiproliferative agent; cycle arrest in G1 and G2 phase |
| 10/16/2008 | US20080255118 Cyanopyrimidinones |
| 10/16/2008 | US20080255117 Sulfonyltryptophanols |
| 10/16/2008 | US20080255116 Therapy for bacteria infections other than Mycibacterium infections; antibiotic resistance |
| 10/16/2008 | US20080255115 (5Z)-5-{[4-(4-pyridinyl)-6-quinolinyl]methylidene}-1,3-thiazolidine-2,4-dione; autoimmune disorders, inflammatory, cardiovascular, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, sperm motility, transplantation rejection |
| 10/16/2008 | US20080255114 2-aminobenzoxazole carboxamides as 5ht3 modulators |
| 10/16/2008 | US20080255113 N-({1-[(cis-1,4-dihydroxycyclohexyl)methyl]piperidin-4-yl}methyl)-1-isopropyl-5-methyl-2-oxo-1, 2-dihydroquinoline-3-carboxamide ethanedioate; gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome |
| 10/16/2008 | US20080255112 Pyrimidine-Substituted Benzimidazole Derivatives as Protein Kinase Inhibitors |
| 10/16/2008 | US20080255111 (4'-{[2-(tert-Butoxycarbonyl)-3-hydroxy-4-(trifluoromethyl)benzyl]oxy}-1,1'-biphenyl-4-yl)acetic acid; vascular restenosis following angioplasty, endarterectomy, percutaneous transluminal coronary angioplasty (PTCA) or stent implantation, blood coagulation diseases |
| 10/16/2008 | US20080255110 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 10/16/2008 | US20080255109 Antigonadotrophins; breast and prostate cancer, endometriosis, benign prostate hyperplasia; regulation of fertility; 4-(3-Chloro-4-{{(4-chloro-benzenesulfonyl)-methyl-amino]-methyl}-thiophene-2-carbonyl)-3,4-dihydro-2H-benzo[1,4]oxazine-2carboxylic acid (3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-amide |
| 10/16/2008 | US20080255108 Novel thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 10/16/2008 | US20080255106 N-(3-Methoxypropyl)-2-[2-(trifluoromethyl)phenyl]-3H-imidazo[4,5-b]pyridine-7-carboxamide hydrochloride; antidepressant, analgesic, anxiolytic agent; amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease, bipolar disease, affective disorders, depression, schizophrenia, cognitive disorder |
| 10/16/2008 | US20080255105 Biphenyl Derivatives and Their Use in Treating Hepatitis C |
| 10/16/2008 | US20080255104 Nsaid Compositions |
| 10/16/2008 | US20080255103 Antihistamine and anti-nausea pharmaceutical compositions for topical application |
| 10/16/2008 | US20080255102 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3-(methylamino)-1-phenylpropan-2-ol; fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence |
| 10/16/2008 | US20080255101 spiro[2H-1,2,4-benzothiadiazine-3,4'-piperidin]-1'-yloxy,7-(aminosulfonyl)-6-chloro-2',2',6',6'-tetramethyl-1,1-dioxide; antidiabetic agent; electrolyte retention; cardiovascular diseases; renovascular diseases; oxidative stress; endothelial dysfunctions; endothelial dysfunctions; cirrhosis; osteoporosis |
| 10/16/2008 | US20080255100 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 10/16/2008 | US20080255099 Use of Diketodithiopiperazine Antibiotics for the Preparation of Antiangiogenic Pharmaceutical Compositions |
| 10/16/2008 | US20080255098 Compositions and Methods for Treatment of Psychiatric Disorders |
| 10/16/2008 | US20080255097 Methods for the Treatment of Substance Abuse and Dependence |
| 10/16/2008 | US20080255096 Blockade or inhibition of brain derived nerve growth factor signal transduction cascade upstream of the BDNF receptor (trkB); GABA receptor agonist is a benzodiazepine; midazolam, diazepam, flurazepam; baclofen, gamma-vinyl-GABA; L-type Ca++ channel antagonist nicardipine, nifedipine and isradipine |
| 10/16/2008 | US20080255095 Benzylamine analogues |
| 10/16/2008 | US20080255094 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor |
| 10/16/2008 | US20080255093 Compositions and methods for treating obesity and related disorders |
| 10/16/2008 | US20080255092 6-Substituted-2,3,4,5-Tetrahydro-1H-Benzo[d]Azepines as 5-Ht2c Receptor Agonists |
| 10/16/2008 | US20080255091 antidiabetic agent; non-insulin dependentdiabetes |
| 10/16/2008 | US20080255090 Ceratamines A and B, and Analogues, Syntheses and Pharmaceutical Compositions Thereof |
| 10/16/2008 | US20080255089 Menopausal or postmenopausal disorders, vasomotor symptoms, urogenital disorders, female sexual dysfunction, breast cancer, depression, diabetes, bone demineralization, and osteoporosis; substituted 2-(p-aminoalkoxyphenyl)-1,1-diphenylethylene derivatives |
| 10/16/2008 | US20080255088 DIBENZO[b,f][1,4]OXAZAPINE COMPOUNDS |
| 10/16/2008 | US20080255087 Use of indolocarbazole antibiotic K252a derivatives as ERK inhibitors; amidation of K252a derivatives |
| 10/16/2008 | US20080255086 Heterocyclic Derivatives |
| 10/16/2008 | US20080255085 Novel Imidazo [4,5-b] Pyridine Derivatives as Inhibitors of Glycogen Synthase Kinase 3 for Use in the Treatment of Dementia and Neurodegenerative Disorders |
| 10/16/2008 | US20080255084 Combination of Organic Compounds |
| 10/16/2008 | US20080255083 New pyridone derivates with mch antagonistic activity and medicaments comprising these compounds |
| 10/16/2008 | US20080255082 Hair and/or Scalp Care Compositions Incorporating Terpenoid Compounds |
| 10/16/2008 | US20080255081 Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin |
| 10/16/2008 | US20080255080 Hydroquinone Ansamycin Formulations |
| 10/16/2008 | US20080255079 Controlled or delayed release of nefopam; fibromyalgia, chronic fatigue syndrome, complex regional pain syndrome, irritable bowel syndrome, myofacial pain or atypical chest pain |
| 10/16/2008 | US20080255078 Menopausal or postmenopausal disorders, vasomotor symptoms, urogenital disorders, female sexual dysfunction, breast cancer, depression, diabetes, bone demineralization, and osteoporosis; carboxy or hydroxyalkoxyalkoxy-group-substituted phenyl at position 2 of 1,1,2-triphenylethylene compounds |
| 10/16/2008 | US20080255077 Drug and Food or Drink for Improving Pancreatic Functions |
| 10/16/2008 | US20080255076 Steroid-Derived Pharmaceutical Compositions |
| 10/16/2008 | US20080255075 Treatment or inhibition of a steroid hormone dependent disorder; reducing spermatogenesis or male virility; 17 beta -hydroxysteroid dehydrogenase (17 beta-HSD) inhibitors; compounds such as 3-(benzylamino)-15alpha-(4-morpholin-4-yl-4-oxobutyl)estra-1(10),2,4-trien-17-one |
| 10/16/2008 | US20080255074 Drug Combination Comprising A Selective Serotonin Reuptake Inhibitor And A Glucocorticoid Receptor Antagonist For The Treatment Of Depression |
| 10/16/2008 | US20080255073 Compounds for sustained release of orally delivered drugs |
| 10/16/2008 | US20080255072 Composition for Inhibition of Cathepsin K |
| 10/16/2008 | US20080255070 Bisphosphonate Compounds and Methods with Enhanced Potency for Multiple Targets including FPPS, GGPPS, AND DPPS |
| 10/16/2008 | US20080255069 Nutraceutical; retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl) carbamoyl]benzoic acid; active metabolite of vitamin A; no adverse effects |
| 10/16/2008 | US20080255068 Tetrahydroquinoline compound; cardiovascular disorders; arteriosclerosis |
| 10/16/2008 | US20080255067 cyanocobalamin at 0.5%, citric acid 0.12%, sodium citrate 0.32%, glycerin 2.23%, benzalkonium chloride 0.02% and 96.79% water; elevating the vitamin B12 levels in the cerebral spinal fluid; intranasally spray |